Pituitary dysfunction of the patient with Fabry disease: an unusual presentation
Öz
Anahtar Kelimeler
fabry disease, pituitary disfunction, metabolic diseases, , hypertension, lysosomal storage disorder
Kaynakça
- Pisani, B. Visciano, G.D. Roux, M. Sabbatini, C. Porto, G. Parenti, M. Imbriaco, Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature. Mol Genet Metab. 2012;107:267–75.
- Van der Tol L, Cassiman D, Houge G. Uncertain diagnosis of Fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up. JIMD Rep. 2014;17:83–90.
- Pasqualim G, Simon L, Sperb-Ludwig F. Fabry disease: a new approach for the screening of females in high-risk groups. Clin Biochem. 2014;47:657–62.
- Yogasundaram H, Kim D, Oudit O, Thompson RB, Weidemann F, Oudit GY. Clinical features, diagnosis, and management of patients with Anderson-Fabry cardiomyopathy. Can J Cardiol. 2017,33:883–97.
- Rombach S, Dekker N, Bouwman M, Linthorst G, Zwinderman A, Wijburg F et al. Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta Mol Basis Dis. 2010,1802:741–8.
- Choi L, Vernon J, Kopach O, Minett M, Mills K et al. The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain. Neurosci Lett. 2015,594:163–68.
- Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30.
- Tojo K, Oota M, Honda H, Shibasaki T, Sakai O. Possible thyroidal involvement in a case of Fabry disease. Intern Med. 1994;33:172–76.
- Nistal M, Paniagua R, Picazo ML. Testicular and epididymal involvement in Fabry’s disease. J. Pathol. 1983;141:113–24.
- Faggiano A, Severino R, Ramundo V, Russo R, Vuolo L, Del Prete M et al. Thyroid function in Fabry disease before and after enzyme replacement therapy. Minerva Endocrinol. 2011;36:1-5.
